Esperion Therapeutics
ESPR
#6564
Rank
S$1.05 B
Marketcap
S$4.11
Share price
0.00%
Change (1 day)
29.38%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2026 (TTM): S-$0.02647

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is S-$0.02582. In 2025 the company made an earnings per share (EPS) of S-$0.17 an increase over its 2024 EPS that were of S-$0.30.

EPS history for Esperion Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.02647-84.23%
2025S-$0.17-43.48%
2024S-$0.30-89.15%
2023S-$2.74-40.28%
2022S-$4.58-62.87%
2021S-$12.3480.38%
2020S-$6.8450.14%
2019S-$4.56-53.18%
2018S-$9.747.41%
2017S-$9.06110.81%
2016S-$4.3047.35%
2015S-$2.920.89%
2014S-$2.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.92-3,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$60.66-235,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$6.70 25,850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S-$0.18 600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S-$0.14 450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S-$0.12 350.00%๐Ÿ‡บ๐Ÿ‡ธ USA